Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aso InternationalTSE:9340 +1.84%65 3-Year ROIIC % is 29.05 as of Jun. 2025, which is 190% above its 10-year median of 10.01. GuruFocus rates TSE:9340 with a GF Score™ of 65/100 and a GF Value™ of 円651.15 (Fairly Valued). The stock has 1 warning sign investors should review. Among 794 Medical Devices & Instruments companies, Aso International ranks better than 75.69% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Aso International's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 29.05%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Aso International's 3-Year ROIIC % or its related term are showing as below:
TSE:9340's 3-Year ROIIC % is ranked better than 75.69% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 1.455
vs TSE:9340: 29.05
Aso International (TSE:9340) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Aso International 3-Year ROIIC % Related Terms
Aso International 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Aso International's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9340 vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Aso International's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aso International 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aso International's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Aso International's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Aso International (TSE:9340) has a 3-Year ROIIC % of 29.05 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Aso International and its competitors. This is 190% above median its historical median of 10.01. According to the industry distribution chart, Aso International ranks #193 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 24.3%.
Is Aso International's 3-Year ROIIC % too high?
Aso International's current 3-Year ROIIC % of 29.05 is 190% above median its 10-year median of 10.01. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.46. Aso International's value of 29.05 is 1896.6% above this industry median. Based on the distribution chart, Aso International ranks #193 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aso International has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aso International's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aso International ranks #193 out of 794 companies for 3-Year ROIIC %. This places Aso International in the top 24% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.46. Aso International's value of 29.05 is 1896.6% above this benchmark. While the company's 10-year median is 10.01 vs. the industry median of 1.46, Aso International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.46, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aso International's current 3-Year ROIIC % of 29.05 is 1896.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Aso International and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aso International's current 3-Year ROIIC % is 29.05, which is 190% above median its own 10-year median of 10.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aso International stock overvalued right now?
Based on GuruFocus' analysis, Aso International (TSE:9340) is currently considered Fairly Valued. The stock's GF Value™ is 円651.15, compared to a current price of 円718.00 — trading 10.3% above its estimated fair value. The current 3-Year ROIIC % is 29.05, which is 190% above median its 10-year median of 10.01 and 1896.6% above the Medical Devices & Instruments industry median of 1.46. Aso International's overall GF Score™ is 65/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Aso International (TSE:9340), the current 3-Year ROIIC % is 29.05 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aso International (TSE:9340) Overvalued in 2026?
Based on GuruFocus' analysis, Aso International stock appears to be overvalued.
The current stock price of 円718.00 is trading 10.3% above its estimated GF Value™ of 円651.15.
GuruFocus considers Aso International to be Fairly Valued.
Key valuation signals for TSE:9340:
3-Year ROIIC %: 29.05 (190% above median its 10-year median of 10.01)
GF Value™: 円651.15 vs. price of 円718.00 (10.3% above fair value)
Industry Position: 1896.6% above the Medical Devices & Instruments median (#193 of 794)
No single metric tells the full story. See the TSE:9340 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aso International Inc is engaged in the manufacturing and sale of orthodontic appliances. The company mainly manufactures and supplies custom-made orthodontic dental prostheses to dental medical institutions. Its product portfolio comprises Aso Liner, Specter 4D Print Retainer, 3D printers for dental prostheses, Harmony, a lingual orthodontic system, and various types of retainers, among others. The group operates in a single segment, the orthodontic business.
65GF Score
Get the complete analysis for TSE:9340
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9340 has been successfully added to your 
